EU can do more for patients with smart use of biosimilar medicines

28 April 2022

Central & Eastern European patients have inequitable access to medicines for life-threatening conditions

25 April 2022

Repurposing: a golden opportunity for patient centric health investment in Europe

6 April 2022

Report shows the future of meeting unmet medical needs relies […]

Call on EU leaders to safeguard access to medicines and build resilience in response to Russia-Ukraine war

23 March 2022

The supply of medicines is critical yet unstable as war […]

“Better patient access to medicines and restoring Europe’s (manufacturing) security of supply more critical than ever” says new President, as Elisabeth Stampa begins mandate

7 March 2022

The Covid-19 pandemic has highlighted the critical link between patient […]

Statement on the war in Ukraine

4 March 2022

Collaboration Since the beginning of the war in Ukraine, Medicines […]

Essential medicines must be included in EU industrial policy plans

3 March 2022

Political ambitions to strengthen EU supply chain resilience following the […]

Electronic product information: new report shows it is time to move from principles to action

24 February 2022

Supply crunch for essential cancer medicines shows the urgent need to revise unsustainable pricing and tendering policies

16 February 2022

Reports of supply shortages of breast cancer medicine (Tamoxifen) in […]

The European Commission needs to prioritise equitable access to biosimilar medicines in Europe

25 January 2022

Over 15 years ago, the world’s first biosimilar was launched. […]